EXCLUSIVE PROMOTION AGREEMENT WITH JEMINCARE IN RELATION TO CMAB007 IN CHINAExclusive Promotion Agreement • June 28th, 2019
Contract Type FiledJune 28th, 2019This announcement is made by Mabpharm Limited (the “Company”, together with its subsidiaries, the “Group”), on a voluntary basis to inform the shareholders and potential investors of the Company about the latest business updates of the Group.